409 filings
Page 8 of 21
8-K
ug60ij7rwwydct
16 Apr 15
Other Events
12:00am
8-K
s5gqycnwdk0o4hq i0j
31 Mar 15
Regulation FD Disclosure
12:00am
8-K
wtumokhjvbxqjys98
20 Mar 15
Other Events
12:00am
8-K
cx6yom4
20 Mar 15
GSK and Theravance announce outcome of US FDA Advisory Committee on BREO® ELLIPTA® in asthma
12:00am
8-K
5zi5pyv
17 Mar 15
Regulation FD Disclosure
12:00am
8-K
bqg5wxtfumefd cm
23 Feb 15
Other Events
12:00am
8-K
7saazhhs1ecui27
18 Feb 15
Results of Operations and Financial Condition
12:00am
8-K
fd0674zdmy 7p5hobmxd
9 Feb 15
Other Events
12:00am
8-K
2fm3xd5m0p61grb
12 Jan 15
Regulation FD Disclosure
12:00am
8-K
o7judryc7i2px0j
23 Dec 14
Regulation FD Disclosure
12:00am
8-K
yeiog0o1
1 Dec 14
Anoro® Ellipta® (umeclidinium/vilanterol) to be reimbursed in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
9d4m3n9i65b 7r7
19 Nov 14
Patient recruitment completed in a world-first COPD lung study being conducted in the unique ‘research city’ setting of Salford, Greater Manchester
12:00am
8-K
4qvquyg6o3x8g h80
13 Nov 14
Regulation FD Disclosure
12:00am
8-K
eeb7mysa 2ti
30 Oct 14
Results of Operations and Financial Condition
12:00am
8-K
rz5u ot7r
28 Oct 14
Other Events
12:00am
8-K
snizti4 9ret10sls8
27 Oct 14
Other Events
12:00am
8-K
ztmwk oxcd8x
21 Oct 14
Regulation FD Disclosure
12:00am
8-K
qeb7ghsvk xeu5lbd9
17 Oct 14
Other Events
12:00am
8-K
vpondrzjgcv
9 Oct 14
Departure of Directors or Certain Officers
12:00am
8-K
dikn7s
19 Sep 14
Departure of Directors or Certain Officers
12:00am